SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 3,600 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | 0.0% | 3,600 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | -66.7% | 3,600 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $3 | -99.9% | 3,600 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $5,000 | -28.6% | 3,600 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $7,000 | -12.5% | 3,600 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $8,000 | -50.0% | 3,600 | 0.0% | 0.00% | -57.1% |
| Q4 2021 | $16,000 | -40.7% | 3,600 | 0.0% | 0.01% | -41.7% |
| Q3 2021 | $27,000 | -20.6% | 3,600 | 0.0% | 0.01% | -20.0% |
| Q2 2021 | $34,000 | +17.2% | 3,600 | 0.0% | 0.02% | +7.1% |
| Q1 2021 | $29,000 | +20.8% | 3,600 | 0.0% | 0.01% | +7.7% |
| Q4 2020 | $24,000 | – | 3,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,711,063 | $14,355,000 | 5.36% |
| Avoro Capital Advisors LLC | 2,151,437 | $18,051,000 | 4.69% |
| Cormorant Asset Management, LP | 2,095,334 | $17,580,000 | 2.81% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,517,000 | 1.46% |
| AlpInvest Partners B.V. | 86,540 | $726,000 | 1.43% |
| Healthcare Value Capital, LLC | 50,000 | $420,000 | 0.60% |
| Aisling Capital LLC | 353,855 | $2,969,000 | 0.52% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $168,000 | 0.26% |
| HAMILTON LANE ADVISORS LLC | 51,582 | $433,000 | 0.21% |
| Spark Investment Management LLC | 106,400 | $891,000 | 0.12% |